ETHZilla Corporation is developing an accumulation vehicle for Ether, the native digital asset of Ethereum. ETHZilla Corporation, formerly known as 180 Life Sciences Corp., is based in PALM BEACH, Fla.
| Revenue (Most Recent Fiscal Year) | $6.55M |
| Net Income (Most Recent Fiscal Year) | $-450.52M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.34 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -6774.57% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -254.74% |
| Return on Assets (Trailing 12 Months) | -132.82% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.33 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.33 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.11 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $12.59 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-39.19 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 20.31M |
| Free Float | 17.25M |
| Market Capitalization | $87.14M |
| Average Volume (Last 20 Days) | 2.48M |
| Beta (Past 60 Months) | 1.01 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 15.10% |
| Percentage Held By Institutions (Latest 13F Reports) | 4.07% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |